According to MarketsandMarkets™, the Lateral Flow Assays Market is projected to reach USD 13.52 billion by 2031 from USD 9.14 billion in 2026, at a CAGR of 8.1% during the forecast period.
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Lateral Flow Assay Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, ...
SHERIDAN, Wyo., Sept. 22, 2026 /PRNewswire/ -- The global lateral flow assay market is projected to grow from USD 11.04 billion in 2026 to USD 16.37 billion by 2031, registering a CAGR of 8.2% during ...
An Iranian knowledge-based company has introduced a nanotechnology-based kit that uses lateral flow assay technology to ...
Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.
Intelligent Bio Solutions expects a sixth U.S. patent for its innovative non-invasive drug testing technology, enhancing market entry plans. Intelligent Bio Solutions Inc. (INBS), a medical technology ...
China’s blood station guidelines permit chemiluminescent immunoassays for transfusion-related infections, but none are approved for Treponema pallidum antibody screening. This study evaluates the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results